Business
WuXi Biologics Releases 2025 Sustainability Report, Advancing Sustainable Growth and Improving Healthcare Access
WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced the release of its 2025 Sustainability Report. The report highlights the Company's continued commitment to placing sustainability at the core of its strategy, empowering global clients, advancing innovative biologics to benefit patients worldwide, and creating long-term value for all stakeholders.
About this update from Wuxi Biologics (cayman) Inc.
[{"type":"list","items":[{"val":[{"type":"text","content":"Contributing to the United Nations Sustainable Development Goals, driving equitable access to healthcare through technology and innovation","length":138,"tagName":"p"}]},{"val":[{"type":"text","content":"Enhancing governance transparency and effectiveness to create long-term value for all stakeholders","length":98,"tagName":"p"}]},{"val":[{"type":"text","content":"Empowering employees and fostering shared value with communities","length":64,"tagName":"p"}]},{"val":[{"type":"text","content":"Accelerating climate actions and strengthening environmental stewardship","length":72,"tagName":"p"}]},{"val":[{"type":"text","content":"Leading Green CRDMO solutions to support global clients' sustainability journeys","length":84,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":456,"olType":false},{"type":"text","content":"HONG KONG, April 29, 2026 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced the release of its 2025 Sustainability Report. The report highlights the Company's continued commitment to placing sustainability at the core of its strategy, empowering global clients, advancing innovative biologics to benefit patients worldwide, and creating long-term value for all stakeholders.","length":475,"tagName":"p"},{"type":"text","content":"Dr. Chris Chen, CEO of WuXi Biologics and Chairman of its ESG Committee, commented, "At WuXi Biologics, we believe that long-term business success is built on our responsibility to people, society, and the planet. As a recognized leader in sustainability, we are committed to working collaboratively with all stakeholders to create positive social and environmental impacts, empowering our global clients through end-to-end Green CRDMO solutions, and driving responsible practices across the entire value chain."","length":522,"tagName":"p"},{"type":"text","content":"Enhancing Governance Transparency and Effectiveness ","length":51,"tagName":"p"},{"type":"text","content":"Guided by a comprehensive sustainability strategy, WuXi Biologics has put in place robust corporate governance structures and well-defined management processes. In alignment with the United Nations Sustainable Development Goals, the company has established science-based, measurable ...